Upal Roy
Upal Roy
Assistant Professor, University of Texas Rio Grande Valley
Verified email at - Homepage
Cited by
Cited by
Antimicrobial activity of marine bacteria associated with sponges from the waters off the coast of South East India
TP Anand, AW Bhat, YS Shouche, U Roy, J Siddharth, SP Sarma
Microbiological research 161 (3), 252-262, 2006
Biodegradation of tributyltins (organotins) by marine bacteria
SK Dubey, U Roy
Applied Organometallic Chemistry 17 (1), 3-8, 2003
Analyses of nanoformulated antiretroviral drug charge, size, shape and content for uptake, drug release and antiviral activities in human monocyte-derived macrophages
AS Nowacek, S Balkundi, JE McMillan, U Roy, A Martinez-Skinner, ...
Journal of controlled release 150 (2), 204-211, 2011
Long-acting nanoformulated antiretroviral therapy elicits potent antiretroviral and neuroprotective responses in HIV-1-infected humanized mice
PK Dash, HE Gendelman, U Roy, S Balkundi, Y Alnouti, RL Mosley, ...
Aids 26 (17), 2135-2144, 2012
Magnetically guided central nervous system delivery and toxicity evaluation of magneto-electric nanocarriers
A Kaushik, RD Jayant, R Nikkhah-Moshaie, V Bhardwaj, U Roy, Z Huang, ...
Scientific reports 6 (1), 25309, 2016
Microglia-derived HIV Nef+ exosome impairment of the blood–brain barrier is treatable by nanomedicine-based delivery of Nef peptides
AD Raymond, P Diaz, S Chevelon, M Agudelo, A Yndart-Arias, H Ding, ...
Journal of neurovirology 22, 129-139, 2016
MRP (ABCC) transporters-mediated efflux of anti-HIV drugs, saquinavir and zidovudine, from human endothelial cells
M Eilers, U Roy, D Mondal
Experimental biology and medicine 233 (9), 1149-1160, 2008
Characterization of nanodiamond-based anti-HIV drug delivery to the brain
U Roy, V Drozd, A Durygin, J Rodriguez, P Barber, V Atluri, X Liu, ...
Scientific reports 8 (1), 1603, 2018
PCL-PEG copolymer based injectable thermosensitive hydrogels
MR Dethe, A Prabakaran, H Ahmed, M Agrawal, U Roy, A Alexander
Journal of Controlled Release 343, 217-236, 2022
Preclinical pharmacokinetics and tissue distribution of long-acting nanoformulated antiretroviral therapy
N Gautam, U Roy, S Balkundi, P Puligujja, D Guo, N Smith, XM Liu, ...
Antimicrobial agents and chemotherapy 57 (7), 3110-3120, 2013
Pharmacodynamic and antiretroviral activities of combination nanoformulated antiretrovirals in HIV-1–infected human peripheral blood lymphocyte–reconstituted mice
U Roy, JE McMillan, Y Alnouti, N Gautum, N Smith, S Balkundi, P Dash, ...
The Journal of infectious diseases 206 (10), 1577-1588, 2012
Mononuclear phagocyte intercellular crosstalk facilitates transmission of cell-targeted nanoformulated antiretroviral drugs to human brain endothelial cells
GD Kanmogne, S Singh, U Roy, X Liu, JE McMillan, S Gorantla, ...
International journal of nanomedicine, 2373-2388, 2012
Comparative manufacture and cell-based delivery of antiretroviral nanoformulations
S Balkundi, AS Nowacek, RS Veerubhotla, H Chen, A Martinez-Skinner, ...
International journal of nanomedicine, 3393-3404, 2011
The potential of HIV-1 nanotherapeutics: from in vitro studies to clinical trials
U Roy, J Rodríguez, P Barber, J das Neves, B Sarmento, M Nair
Nanomedicine 10 (24), 3597-3609, 2015
UPLC–MS/MS quantification of nanoformulated ritonavir, indinavir, atazanavir, and efavirenz in mouse serum and tissues
J Huang, N Gautam, SPR Bathena, U Roy, JE McMillan, HE Gendelman, ...
Journal of Chromatography B 879 (23), 2332-2338, 2011
Preparation and characterization of anti-HIV nanodrug targeted to microfold cell of gut-associated lymphoid tissue
U Roy, H Ding, S Pilakka-Kanthikeel, AD Raymond, V Atluri, A Yndart, ...
International journal of nanomedicine, 5819-5835, 2015
Mesenchymal stem cell derived hematopoietic cells are permissive to HIV-1 infection
TZ Nazari-Shafti, E Freisinger, U Roy, CT Bulot, C Senst, CL Dupin, ...
Retrovirology 8, 1-12, 2011
Montelukast is a potent and durable inhibitor of multidrug resistance protein 2 (MRP2)-mediated efflux of taxol and saquinavir
U Roy, G Chakravarty, KH Zu Bentrup, D Mondal
Biological & pharmaceutical bulletin 32 (12), 2002-09, 2009
Specific increase in MDR1 mediated drug-efflux in human brain endothelial cells following co-exposure to HIV-1 and saquinavir
U Roy, C Bulot, K Honer zu Bentrup, D Mondal
PloS one 8 (10), e75374, 2013
Cycloviolacin O2 (CyO2) suppresses productive infection and augments the antiviral efficacy of nelfinavir in HIV‐1 infected monocytic cells
SL Gerlach, M Yeshak, U Göransson, U Roy, R Izadpanah, D Mondal
Peptide Science 100 (5), 471-479, 2013
The system can't perform the operation now. Try again later.
Articles 1–20